Manns M - Search Results

1

Clinical relevance of mutations in the precore genome of the hepatitis B virus.

Tillmann H, Trautwein C, Walker D, Michitaka K, Kubicka S, Böker K, Manns M. Tillmann H, et al. Among authors: manns m. Gut. 1995 Oct;37(4):568-73. doi: 10.1136/gut.37.4.568. Gut. 1995. PMID: 7489947 Free PMC article.

2

Low incidence of p53 mutations in European hepatocellular carcinomas with heterogeneous mutation as a rare event.

Kubicka S, Trautwein C, Schrem H, Tillmann H, Manns M. Kubicka S, et al. Among authors: manns m. J Hepatol. 1995 Oct;23(4):412-9. doi: 10.1016/0168-8278(95)80199-5. J Hepatol. 1995. PMID: 8655958

3

Target gene modulation in hepatocellular carcinomas by decreased DNA-binding of p53 mutations.

Kubicka S, Trautwein C, Niehof M, Manns M. Kubicka S, et al. Among authors: manns m. Hepatology. 1997 Apr;25(4):867-73. doi: 10.1002/hep.510250414. Hepatology. 1997. PMID: 9096590

4

Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area.

Kubicka S, Rudolph KL, Hanke M, Tietze MK, Tillmann HL, Trautwein C, Manns M. Kubicka S, et al. Among authors: manns m. Liver. 2000 Jul;20(4):312-8. doi: 10.1034/j.1600-0676.2000.020004312.x. Liver. 2000. PMID: 10959810

5

K-ras mutations in the bile of patients with primary sclerosing cholangitis.

Kubicka S, Kühnel F, Flemming P, Hain B, Kezmic N, Rudolph KL, Manns M, Meier PN. Kubicka S, et al. Among authors: manns m. Gut. 2001 Mar;48(3):403-8. doi: 10.1136/gut.48.3.403. Gut. 2001. PMID: 11171833 Free PMC article.

6

p53 represses CAAT enhancer-binding protein (C/EBP)-dependent transcription of the albumin gene. A molecular mechanism involved in viral liver infection with implications for hepatocarcinogenesis.

Kubicka S, Kühnel F, Zender L, Rudolph KL, Plümpe J, Manns M, Trautwein C. Kubicka S, et al. Among authors: manns m. J Biol Chem. 1999 Nov 5;274(45):32137-44. doi: 10.1074/jbc.274.45.32137. J Biol Chem. 1999. PMID: 10542249 Free article.

7

NFkappaB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis.

Kühnel F, Zender L, Paul Y, Tietze MK, Trautwein C, Manns M, Kubicka S. Kühnel F, et al. Among authors: manns m. J Biol Chem. 2000 Mar 3;275(9):6421-7. doi: 10.1074/jbc.275.9.6421. J Biol Chem. 2000. PMID: 10692445 Free article.

8

Fatal clinical course of ornithine transcarbamylase deficiency in an adult heterozygous female patient.

Heringlake S, Böker K, Manns M. Heringlake S, et al. Among authors: manns m. Digestion. 1997;58(1):83-6. doi: 10.1159/000201428. Digestion. 1997. PMID: 9018015

9

Different cellular patterns associated with hepatitis C virus reactivation, cytomegalovirus infection, and acute rejection in liver transplant patients monitored with transplant aspiration cytology.

Lautenschlager I, Nashan B, Schlitt HJ, Hoshino K, Ringe B, Tillmann HL, Manns M, Wonigeit K, Pichlmayr R. Lautenschlager I, et al. Among authors: manns m. Transplantation. 1994 Dec 27;58(12):1339-45. Transplantation. 1994. PMID: 7809926

10

[Therapy of persistent bleeding esophageal varices using intrahepatic portosystemic stent shunt and immediate liver transplantation].

Schlitt HJ, Rosenthal H, Böker K, Manns M, Pichlmayr R. Schlitt HJ, et al. Among authors: manns m. Chirurg. 1997 Apr;68(4):385-8. doi: 10.1007/s001040050202. Chirurg. 1997. PMID: 9206633 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,824 results

Search Page

Filters